Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions
Open Access
- 19 April 2020
- journal article
- review article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 245 (11), 964-969
- https://doi.org/10.1177/1535370220920540
Abstract
Early availability of the sequence, the genetic material of SARS-CoV-2 (the virus that causes COVID-19), has prompted efforts towards identifying a safe and effective vaccine in the current public health emergency. To that end, understanding the pathophysiology of disease is crucial for scientists around the world. Since conventional vaccine development and manufacturing may take several years, it is important to think about alternative strategies that we could use to mitigate imminent catastrophe. We hope that this article will open up new avenues and provide insights that could potentially save hundreds of lives affected by COVID-19.This publication has 31 references indexed in Scilit:
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus EntryJournal of Virology, 2020
- Return of the Coronavirus: 2019-nCoVViruses, 2020
- Cross‐species transmission of the newly identified coronavirus 2019‐nCoVJournal of Medical Virology, 2020
- Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic reviewTravel Medicine and Infectious Disease, 2018
- Middle East Respiratory Syndrome: Emergence of a Pathogenic Human CoronavirusAnnual Review of Medicine, 2017
- Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirusCold Spring Harbor Molecular Case Studies, 2016
- Coronaviruses — drug discovery and therapeutic optionsNature Reviews Drug Discovery, 2016
- A SARS-like cluster of circulating bat coronaviruses shows potential for human emergenceNature Medicine, 2015
- Super-spreaders in infectious diseasesInternational Journal of Infectious Diseases, 2011
- Viral Loads in Clinical Specimens and SARS ManifestationsEmerging Infectious Diseases, 2004